The Use of Peptide and Protein Vectors to Cross the Blood-Brain Barrier for the Delivery of Therapeutic Concentration of Biologics-Reference-Cited by-同舟云学术

The Use of Peptide and Protein Vectors to Cross the Blood-Brain Barrier for the Delivery of Therapeutic Concentration of Biologics

Published:2020-11-20 Issue: Volume: Page:119-147
ISSN:0893-2336
Container-title:Neuromethods
language:
Short-container-title:

Author:

Tian Mei Mei,Gabathuler Reinhard

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-0716-0838-8_5

Reference213 articles.

1. Domínguez A, Álvarez A, Hilario E et al (2013) Central nervous system diseases and the role of the blood-brain barrier in their treatment. Neurosci Discov 1:11. https://doi.org/10.7243/2052-6946-1-3

2. Ereshefshy L, Evans R, Sood R, Williamson D, English BA (2016) Venturing into a new era of CNS drug development to improve success. Waltham, MA: Parexel. https://www.parexel.com/application/files_previous/4314/4113/4032/Venturing_Into_a_New_Era_of_CNS_Drug_Development_to_Improve_Success.pdf (accessed December 2, 2016)

3. Jain KK (2014) Global drug delivery in central nervous system diseases – technologies, markets, companies. Research and Markets, Basel

4. Kesselheim AS, Hwang TJ, Franklin JM (2015) Two decades of new drug development for central nervous system disorders. Nat Rev Drug Discov 14:815–816. https://doi.org/10.1038/nrd4793

5. Thorne RG, Frey WH (2001) Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet 40:907–946. https://doi.org/10.2165/00003088-200140120-00003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Nanotechnology in Clinical Research;Nanomaterials in Clinical Therapeutics;2022-08-15